196 related articles for article (PubMed ID: 36599593)
1. First-in-Human Dedicated Leaflet Splitting Device for Prevention of Coronary Obstruction in Transcatheter Aortic Valve Replacement.
Dvir D; Leon MB; Abdel-Wahab M; Unbehaun A; Kodali S; Tchetche D; Pibarot P; Leipsic J; Blanke P; Gerckens U; Manoharan G; Harari E; Hellou E; Wolak A; Ben-Assa E; Jubeh R; Shuvy M; Koifman E; Klein C; Kempfert J
JACC Cardiovasc Interv; 2023 Jan; 16(1):94-102. PubMed ID: 36599593
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter Laceration of Aortic Leaflets to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: Concept to First-in-Human.
Khan JM; Dvir D; Greenbaum AB; Babaliaros VC; Rogers T; Aldea G; Reisman M; Mackensen GB; Eng MHK; Paone G; Wang DD; Guyton RA; Devireddy CM; Schenke WH; Lederman RJ
JACC Cardiovasc Interv; 2018 Apr; 11(7):677-689. PubMed ID: 29622147
[TBL] [Abstract][Full Text] [Related]
3. The BASILICA Trial: Prospective Multicenter Investigation of Intentional Leaflet Laceration to Prevent TAVR Coronary Obstruction.
Khan JM; Greenbaum AB; Babaliaros VC; Rogers T; Eng MH; Paone G; Leshnower BG; Reisman M; Satler L; Waksman R; Chen MY; Stine AM; Tian X; Dvir D; Lederman RJ
JACC Cardiovasc Interv; 2019 Jul; 12(13):1240-1252. PubMed ID: 31202947
[TBL] [Abstract][Full Text] [Related]
4. Transcatheter Aortic Valve-in-Valve Replacement for Degenerated Stentless Bioprosthetic Aortic Valves: Results of a Multicenter Retrospective Analysis.
Miller M; Snyder M; Horne BD; Harkness JR; Doty JR; Miner EC; Jones KW; O'Neal KR; Reid BB; Caine WT; Clayson SE; Lindley E; Gardner B; Connors RC; Bowles BJ; Whisenant BK
JACC Cardiovasc Interv; 2019 Jul; 12(13):1217-1226. PubMed ID: 31272667
[TBL] [Abstract][Full Text] [Related]
5. Prevention of coronary obstruction in patients at risk undergoing transcatheter aortic valve implantation: the Hamburg BASILICA experience.
Westermann D; Ludwig S; Kalbacher D; Spink C; Linder M; Bhadra OD; Nikorowitsch J; Waldschmidt L; Demal T; Voigtländer L; Schaefer A; Seiffert M; Pecha S; Schofer N; Greenbaum AB; Reichenspurner H; Blankenberg S; Conradi L; Schirmer J
Clin Res Cardiol; 2021 Dec; 110(12):1900-1911. PubMed ID: 34156524
[TBL] [Abstract][Full Text] [Related]
6. Risk Assessment of Coronary Obstruction During Transcatheter Aortic Valve Replacement: Insights From Post-BASILICA Computed Tomography.
Kitamura M; Wilde J; Dumpies O; Richter I; Obradovic D; Krieghoff C; Gohmann RF; Majunke N; Desch S; Gutberlet M; Borger M; Marwan M; Thiele H; Holzhey D; Abdel-Wahab M
JACC Cardiovasc Interv; 2022 Mar; 15(5):496-507. PubMed ID: 35272774
[TBL] [Abstract][Full Text] [Related]
7. Bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction technique in transcatheter aortic valve-in-valve procedures: a single-center initial experience.
Tagliari AP; Miura M; Gavazzoni M; Haager PK; Russo G; Pozzoli A; Zuber M; Jörg L; Rickli H; Gennari M; Maisano F; Taramasso M
J Cardiovasc Med (Hagerstown); 2021 Mar; 22(3):212-221. PubMed ID: 32890234
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic and Mid-Term Outcomes for Transcatheter Aortic Valve Replacement in Degenerated Internally Stented Valves.
AlBadri A; Joseph J; Patel V; Patel D; Koren O; Cheng W; Jilaihawi H; Makkar R
JACC Cardiovasc Interv; 2023 Mar; 16(5):542-554. PubMed ID: 36922040
[TBL] [Abstract][Full Text] [Related]
9. Leaflet-splitting device to prevent coronary artery obstruction in valve-in-valve transcatheter aortic valve implantation.
Van Praet KM; Klein C; Kukucka M; Kempfert J; Kofler M; Gerckens U; Dvir D; Falk V; Unbehaun A
Multimed Man Cardiothorac Surg; 2022 Dec; 2022():. PubMed ID: 36468494
[TBL] [Abstract][Full Text] [Related]
10. Equipment entrapment during redo-TAVR with successful BASILICA procedure.
Qureshi WT; Parker M; Walker J; Kakouros N
Catheter Cardiovasc Interv; 2021 Aug; 98(2):E320-E323. PubMed ID: 33484070
[TBL] [Abstract][Full Text] [Related]
11. Chimney Stenting vs BASILICA for Prevention of Acute Coronary Obstruction During Transcatheter Aortic Valve Replacement.
Mangieri A; Richter I; Gitto M; Abdelhafez A; Bedogni F; Lanz J; Montorfano M; Unbehaun A; Giannini F; Nerla R; Taramasso M; Ielasi A; Rudolph T; Ferlini M; Ribichini F; Poletti E; Latib A; Colombo A; Van Mieghem NM; Thiele H; Abdel-Wahab M
JACC Cardiovasc Interv; 2024 Mar; 17(6):742-752. PubMed ID: 38538170
[TBL] [Abstract][Full Text] [Related]
12. Transcatheter aortic valve replacement for structural degeneration of previously implanted transcatheter valves (TAVR-in-TAVR): a systematic review.
Gallo M; Fovino LN; Blitzer D; Doulamis IP; Guariento A; Salvador L; Tagliari AP; Ferrari E
Eur J Cardiothorac Surg; 2022 May; 61(5):967-976. PubMed ID: 34662376
[TBL] [Abstract][Full Text] [Related]
13. Coronary ostial eccentricity in severe aortic stenosis: Guidance for BASILICA transcatheter leaflet laceration.
Komatsu I; Leipsic J; Webb JG; Blanke P; Mackensen GB; Don CW; McCabe JM; Rumer C; Tan CW; Levin DB; Ramos M; Aldea GS; Reisman M; Wijeysundera HC; Radhakrishnan S; Sathananthan J; Piazza N; Kornowski R; Dvir D
J Cardiovasc Comput Tomogr; 2020; 14(6):516-519. PubMed ID: 32199758
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of intravascular ultrasound to assess coronary occlusion after transcatheter aortic valve replacement.
Valvo R; Costa G; Tamburino C; Barbanti M
Catheter Cardiovasc Interv; 2022 Apr; 99(5):1687-1690. PubMed ID: 35114070
[TBL] [Abstract][Full Text] [Related]
15. Leaflet modification or chimney stenting in patients at risk for coronary artery obstruction in valve-in-valve procedure for a failed surgical bioprosthetic aortic valve.
Montarello NJ; Quagliana A; Søndergaard L; De Backer O
Catheter Cardiovasc Interv; 2023 Feb; 101(3):655-659. PubMed ID: 36651342
[TBL] [Abstract][Full Text] [Related]
16. Novel valve-in-surgical bioprosthetic transcatheter aortic valve replacement: Undermining iatrogenic coronary obstruction with radiofrequency needle (UNICORN).
Buchanan CE; Iskander M; Anwaruddin S; Mason PJ
Catheter Cardiovasc Interv; 2024 May; 103(6):1069-1073. PubMed ID: 38584521
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Coronary Artery Obstruction Risk During Transcatheter Aortic Valve Replacement Utilising 3D-Printing.
Russo JJ; Yuen T; Tan J; Willson AB; Gurvitch R
Heart Lung Circ; 2022 Aug; 31(8):1134-1143. PubMed ID: 35365428
[TBL] [Abstract][Full Text] [Related]
18. Bioprosthetic aortic valve leaflet disruption with high energy electrocautery to prevent coronary artery obstruction during valve-in-valve transcatheter aortic valve replacement.
Nelson BC; Chadderdon S; Song H; Zahr FE
Catheter Cardiovasc Interv; 2019 Jan; 93(1):164-168. PubMed ID: 30298684
[TBL] [Abstract][Full Text] [Related]
19. Early Outcomes for Valve-in-valve Transcatheter Aortic Valve Replacement in Degenerative Freestyle Bioprostheses.
Sang SLW; Beute T; Heiser J; Berkompas D; Fanning J; Merhi W
Semin Thorac Cardiovasc Surg; 2018 Autumn; 30(3):262-268. PubMed ID: 29158054
[TBL] [Abstract][Full Text] [Related]
20. An alternative solution for patient with high risk of coronary obstruction underwent TAVI procedure using a novel second-generation device - a case series.
Qian H; Chen Y; Cheng Z; Guo Y
J Cardiothorac Surg; 2019 Feb; 14(1):47. PubMed ID: 30819225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
